The first ever prescription pill to boost women's libido has won the approval of US regulators. Addyi got the final nod from the Food and Drug Administration (FDA) on Tuesday after three 24-week trials showed it to offer an increase in sexual desire in premenopausal women, though the agency does warn of side effects that include low blood pressure and fainting.
The term "designer drug" may soon refer less to the illicit kind and
more to custom creations by the pharmaceutical industry. Aprecia
Pharmaceuticals Company has just had its proprietary ZipDose Technology
platform approved by the US Food and Drug Administration (FDA). This
marks the very first instance that the FDA has given the green light for
a 3D-printed drug product.